Related Experiment Video
Updated: Jun 14, 2025

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Lead-Induced Nephrotoxicity and Its Therapeutic Interventions: An Updated Review
Ankit Kumar Bharti S1, Abilash Valsala Gopalakrishnan2
1Department of Biomedical Sciences, School of Bio-Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
Abstract:
Lead is a major environmental pollutant and a poisonous substance that induces oxidative stress. It is responsible for several serious diseases associated with its toxicity. Its presence in the environment mostly affects children, mining workers, and pregnant women. Multiple studies are underway to investigate the mechanisms of lead-induced renal damage and associated diseases. Several mechanisms contribute to lead-induced nephrotoxicity, resulting in nephron damage and eventually inducing acute kidney injury (AKI) and chronic kidney disease (CKD). Chelation therapy is currently the main approach for the treatment of lead toxicity. However, recent research is increasingly exploring the potential of naturally occurring bioactive compounds, plant-derived extracts, and nanotechnology-based strategies as alternative treatments for lead poisoning. This review focuses on the mechanistic effects of toxicity and the various categories of compounds that have a beneficial impact on lead-induced renal toxicity. Plant extracts are significant in mitigating lead intoxication. A combination of phyto-bioactive and chelating agents is used for the treatment of lead toxicity. Cerium- and selenium-derived nanoparticles are used for therapeutic purposes. Further research is required to investigate the therapeutic potential of these therapeutic interventions.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Inotropic Agents
Antihypertensive Drugs: Direct Renin Inhibitors

